Literature DB >> 1437150

Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.

W S Wu1, J K Lin, F Y Wu.   

Abstract

A two-stage (initiation and promotion) model of chemical transformation of mouse embryonic fibroblasts was used to elucidate the molecular mechanisms of tumor promotion in vitro. C3H10T1/2 cells which had been initiated with a subcarcinogenic dose (0.5 micrograms ml-1) of benzo[a]pyrene (B[a]P) were isolated after 12-O-tetradecanoyl phorbol 13-acetate (TPA) treatment lasting 12, 24 or 36 days. These series of partially promoted cells were designated T-12, T-24 and T-36 cells. T-12 and T-24 cells exhibited higher anchorage-independent growth on soft agar in the presence of TPA than did the initiated or T-36 cells. Cytosolic protein kinase C (PKC) in the resting state was slightly depleted in T-24 and T-36 cells. Proteolytic down-regulation of membrane-bound PKC was enhanced in T-12 cells compared with the initiated cells after 3 h of TPA treatment. Induction of c-fos and c-jun proto-oncogene expression increased two- to threefold in T-12 cells. Moreover, the basal level of c-fos mRNA progressively increased in T-12, T-24 and T-36 cells. As compared with other cell types, T-12 cells had the highest AP-1 DNA-binding activity at both the basal level and at 30 min after TPA treatment. These results indicate that deregulation of the TPA-induced cellular responses occurs in the cells at various stages of tumor promotion, and might be associated with transforming processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437150

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.

Authors:  E-K Tensing; J Ma; M Hukkanen; H S Fox; T-F Li; J Törnwall; Y T Konttinen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

2.  Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.

Authors:  C Peng; W Zeng; J Su; Y Kuang; Y He; S Zhao; J Zhang; W Ma; A M Bode; Z Dong; X Chen
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway.

Authors:  Ga-Eun Lee; Cheol-Jung Lee; Hyun-Jung An; Han Chang Kang; Hye Suk Lee; Joo Young Lee; Sei-Ryang Oh; Sung-Jun Cho; Dae Joon Kim; Yong-Yeon Cho
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.